| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6daa1dcb0edd78a67fffa02d9850f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66dbe43759772f798b52e69cb2123686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c190c99174dfe46deef72ae3ad792590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc71b3ce116916ba09fc5ec5674b1330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbc85107e2727af2bf6256511d2e90b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8139 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb083e715b3b506390e0adde14f92d35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b495dcdd74f910a66742fc9c11bf24c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed4304e09ed00af69dfb6f4be14cbacc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7678e569053dba70d83c8e82998486 |
| publicationDate |
2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010064435-A1 |
| titleOfInvention |
Method for measuring cystatin c in human body fluid |
| abstract |
Disclosed is a particle-enhanced immunoassay method for cystatin C in a human body fluid, which has higher specificity, is more inexpensive, and can be automated more readily compared with conventional assay methods in which polyclonal antibodies having low specificity or monoclonal antibodies having high specificity but having poor aggregability have been used in large quantities.nThe particle-enhanced immunoassay method utilizes a combination of an antibody-sensitized particle comprising an insoluble carrier particle and an anti-human cystatin C monoclonal antibody having higher affinity and bound to the particle and an antibody-sensitized particle comprising the insoluble carrier particle and an anti-human cystatin C monoclonal antibody having a different recognition site from that of the aforementioned monoclonal antibody and having a relatively lower affinity, wherein the quantity of each of the human cystatin C monoclonal antibodies bound to the insoluble carrier particle is less than 5 wt% relative to the weight of the antibody-sensitized particle. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012133482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012133482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5914333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6110786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013115283-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103443628-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10119963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012008584-A1 |
| priorityDate |
2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |